Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Dupont

Showing results (531-540 of 829) with videos related to

Pageof 83
Sort By:
Ultrasonics|May 1, 2021
A micro-transducer matrix design for the detection of flexural guided wavesH El Rammouz, F Benmeddour, J Assaad, et al.
American Journal of Epidemiology|November 1, 1989
An observational study of naturally acquired immunity to rotaviral diarrhea in a cohort of 363 Egyptian children. Calculation of risk for second episodes using age-specific person-years of observationR R Reves, M M Hossain, K Midthun, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1984
Furazolidone versus ampicillin in the treatment of traveler's diarrheaH L DuPont, C D Ericsson, E Galindo, et al.
Journal of Travel Medicine|January 24, 2007
Rifaximin treatment of pathogen-negative travelers' diarrheaHerbert L DuPont, Robert Haake, David N Taylor, et al.
Transplantation Proceedings|June 23, 2011
Neutrophilic reversible airways dysfunction after liver transplantation: a case reportG M Verleden, R Vos, S De Vleeschauwer, et al.
Gastroenterology|March 1, 1993
Zaldaride maleate, an intestinal calmodulin inhibitor, in the therapy of travelers' diarrheaH L DuPont, C D Ericsson, J J Mathewson, et al.
Clinical and Vaccine Immunology : CVI|March 12, 2010
Pilot study of whole-blood gamma interferon response to the Vibrio cholerae toxin B subunit and resistance to enterotoxigenic Escherichia coli-associated diarrheaJose Flores, Herbert L DuPont, Mercedes Paredes-Paredes, et al.
The Journal of Hospital Infection|August 30, 2008
A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibioticsK W Garey, T K Dao-Tran, Z D Jiang, et al.
The American Journal of Gastroenterology|October 19, 2002
A double blind, randomized, placebo-controlled study of SP-303 (Provir) in the symptomatic treatment of acute diarrhea among travelers to Jamaica and MexicoDaniel DiCesare, Herbert L DuPont, John J Mathewson, et al.
The American Journal of the Medical Sciences|September 22, 2011
Moderate to high use of opioid analgesics are associated with an increased risk of Clostridium difficile infectionAndrea L Mora, Miguel Salazar, Juan Pablo-Caeiro, et al.
Pageof 83

Showing results (531-540 of 829) with videos related to

Sort By:
Pageof 83
Ultrasonics|May 1, 2021
A micro-transducer matrix design for the detection of flexural guided wavesH El Rammouz, F Benmeddour, J Assaad, et al.
American Journal of Epidemiology|November 1, 1989
An observational study of naturally acquired immunity to rotaviral diarrhea in a cohort of 363 Egyptian children. Calculation of risk for second episodes using age-specific person-years of observationR R Reves, M M Hossain, K Midthun, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1984
Furazolidone versus ampicillin in the treatment of traveler's diarrheaH L DuPont, C D Ericsson, E Galindo, et al.
Journal of Travel Medicine|January 24, 2007
Rifaximin treatment of pathogen-negative travelers' diarrheaHerbert L DuPont, Robert Haake, David N Taylor, et al.
Transplantation Proceedings|June 23, 2011
Neutrophilic reversible airways dysfunction after liver transplantation: a case reportG M Verleden, R Vos, S De Vleeschauwer, et al.
Gastroenterology|March 1, 1993
Zaldaride maleate, an intestinal calmodulin inhibitor, in the therapy of travelers' diarrheaH L DuPont, C D Ericsson, J J Mathewson, et al.
Clinical and Vaccine Immunology : CVI|March 12, 2010
Pilot study of whole-blood gamma interferon response to the Vibrio cholerae toxin B subunit and resistance to enterotoxigenic Escherichia coli-associated diarrheaJose Flores, Herbert L DuPont, Mercedes Paredes-Paredes, et al.
The Journal of Hospital Infection|August 30, 2008
A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibioticsK W Garey, T K Dao-Tran, Z D Jiang, et al.
The American Journal of Gastroenterology|October 19, 2002
A double blind, randomized, placebo-controlled study of SP-303 (Provir) in the symptomatic treatment of acute diarrhea among travelers to Jamaica and MexicoDaniel DiCesare, Herbert L DuPont, John J Mathewson, et al.
The American Journal of the Medical Sciences|September 22, 2011
Moderate to high use of opioid analgesics are associated with an increased risk of Clostridium difficile infectionAndrea L Mora, Miguel Salazar, Juan Pablo-Caeiro, et al.
Pageof 83